Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
US Gold Corp
USAU
$258M
| $1.09M | ﹤0.01% |
119,936
+14,944
| +14% | +$124K |
|
3277
Kyverna Therapeutics
KYTX
$484M
| $1.09M | ﹤0.01% |
563,974
+24,292
| +5% | +$71.8K |
|
3278
ATS Corp
ATS
$2.05B
| $1.09M | ﹤0.01% |
43,250
+2,196
| +5% | +$61.3K |
|
3279
Pyxis Oncology
PYXS
$236M
| $1.09M | ﹤0.01% |
1,109,098
+26,649
| +2% | +$35.6K |
|
3280
Waldencast
WALD
$178M
| $1.08M | ﹤0.01% |
361,661
+2,826
| +0.8% | +$9.14K |
|
3281
Westwood Holdings Group
WHG
$190M
| $1.08M | ﹤0.01% |
66,894
+1,064
| +2% | +$16.6K |
|
|
VXRT
3282
DELISTED
Vaxart
VXRT
| $1.08M | ﹤0.01% |
2,660,119
+58,980
| +2% | +$37.8K |
|
3283
Crawford & Co Class B
CRD.B
$604M
| $1.08M | ﹤0.01% |
94,698
+130
| +0.1% | +$1.49K |
|
3284
Veritone
VERI
$122M
| $1.07M | ﹤0.01% |
461,245
+84,189
| +22% | +$244K |
|
3285
CervoMed
CRVO
$26.6M
| $1.07M | ﹤0.01% |
116,481
+1,646
| +1% | +$6.27K |
|
3286
Hanover Bancorp
HNVR
$198M
| $1.07M | ﹤0.01% |
48,555
+3,712
| +8% | +$88.8K |
|
3287
Hurco Companies Inc
HURC
$143M
| $1.06M | ﹤0.01% |
68,634
+3,385
| +5% | +$64.4K |
|
3288
Immunic
IMUX
$195M
| $1.06M | ﹤0.01% |
97,615
+2,386
| +3% | +$25.8K |
|
|
SAND
3289
DELISTED
Sandstorm Gold
SAND
| $1.06M | ﹤0.01% |
139,502
+9,753
| +8% | +$60.9K |
|
|
BIOA
3290
BioAge Labs
BIOA
$538M
| $1.06M | ﹤0.01% |
282,029
+25,034
| +10% | +$116K |
|
|
PPIH
3291
Perma-Pipe International
PPIH
$215M
| $1.05M | ﹤0.01% |
84,756
+2,743
| +3% | +$39.2K |
|
|
APLT
3292
DELISTED
Applied Therapeutics
APLT
| $1.05M | ﹤0.01% |
2,151,392
+67,250
| +3% | +$39.6K |
|
3293
Alto Neuroscience
ANRO
$1.11B
| $1.05M | ﹤0.01% |
486,859
+14,202
| +3% | +$50.8K |
|
3294
RCM Technologies
RCMT
$208M
| $1.05M | ﹤0.01% |
67,288
+4,397
| +7% | +$82.2K |
|
3295
Ohio Valley Banc Corp
OVBC
$205M
| $1.05M | ﹤0.01% |
40,144
+1,896
| +5% | +$50.3K |
|
3296
Establishment Labs
ESTA
$2.28B
| $1.05M | ﹤0.01% |
25,618
+22
| +0.1% | +$820 |
|
3297
Inseego
INSG
$90.5M
| $1.04M | ﹤0.01% |
127,817
+3,696
| +3% | +$40.4K |
|
3298
Purple Innovation
PRPL
$41.7M
| $1.04M | ﹤0.01% |
55,021
+1,138
| +2% | +$26.2K |
|
3299
Galectin Therapeutics
GALT
$348M
| $1.04M | ﹤0.01% |
852,706
-17,883
| -2% | -$25.1K |
|
3300
INNOVATE Corp
VATE
$165M
| $1.04M | ﹤0.01% |
132,166
+8,492
| +7% | +$77K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.